Differential responses to metabolic disease can be observed in animals pre-treated with antibiotic, likely due to perturbation or reduction of the constitutive microbiome. Depending on the antibiotic pre-treatment paradigm selected, evaluation of obesity and metabolism phenotype in antibiotic pre-treated animals enables assessment of phenotypes’ sensitivity toward broad microbiome depletion, species-specific depletion, or function-specific depletion. Data assessing metabolic phenotypes in normal mice, as well as from the high fat diet-induced obesity model, utilizing animals pre-treated with an antibiotic cocktail intended for maximum microbiome depletion is shown. A subset of animals were treated with a murine fecal microbial transplant (FMT).
Animals are weighed daily, and body weight change as compared to Day 0 is calculated. The AUC is calculated to compare treatment arms and is shown in the inset. (***p<0.005).
Animals are fasted and blood glucose is measured via glucose monitor. Food is returned to animals and blood glucose is re-measured via glucose monitor the next day.
Bone phenotypes are assessed via dual-energy x-ray absorptiometry (DEXA) analysis. (*p<0.05; **p<0.01; ***p<0.005; ****p<0.001).
Tissue phenotypes are assessed via dual-energy x-ray absorptiometry (DEXA) analysis. (*p<0.05).
Animals are weighed daily, and body weight change as compared to day of HFD administration (Day 22) is calculated. The AUC is calculated to compare treatment arms and is shown in the inset. (*p<0.05; **p<0.01; ***p<0.005; ****p<0.001).
Animals are fasted and blood glucose is measured via glucose monitor. Food is returned to animals and blood glucose is re-measured via glucose monitor the next day.
Bone phenotypes are assessed via dual-energy x-ray absorptiometry (DEXA) analysis.
Tissue phenotypes are assessed via dual-energy x-ray absorptiometry (DEXA) analysis. (**p<0.01; ***p<0.005; ****p<0.001).